Gargoyle Investment Advisor L.L.C. Maintains Stake in Hill-Rom Holdings Inc. (HRC)
Gargoyle Investment Advisor L.L.C. held its position in Hill-Rom Holdings Inc. (NYSE:HRC) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 52,857 shares of the medical technology company’s stock at the end of the second quarter. Hill-Rom Holdings comprises about 1.0% of Gargoyle Investment Advisor L.L.C.’s portfolio, making the stock its 26th largest position. Gargoyle Investment Advisor L.L.C.’s holdings in Hill-Rom Holdings were worth $2,667,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of the company. BlackRock Institutional Trust Company N.A. boosted its position in Hill-Rom Holdings by 270.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 6,359,964 shares of the medical technology company’s stock worth $319,906,000 after buying an additional 4,642,638 shares during the last quarter. Norges Bank bought a new position in Hill-Rom Holdings during the fourth quarter worth $42,825,000. AXA boosted its position in Hill-Rom Holdings by 13,543.5% in the first quarter. AXA now owns 313,800 shares of the medical technology company’s stock worth $15,784,000 after buying an additional 311,500 shares during the last quarter. Bank of Montreal Can bought a new position in Hill-Rom Holdings during the second quarter worth $15,483,000. Finally, Foundry Partners LLC bought a new position in Hill-Rom Holdings during the second quarter worth $9,209,000. 83.11% of the stock is owned by hedge funds and other institutional investors.
Shares of Hill-Rom Holdings Inc. (NYSE:HRC) traded up 1.67% during trading on Friday, reaching $61.98. 427,134 shares of the company’s stock traded hands. The stock has a 50-day moving average of $59.20 and a 200-day moving average of $52.83. The company has a market capitalization of $4.06 billion, a price-to-earnings ratio of 63.83 and a beta of 1.06. Hill-Rom Holdings Inc. has a 1-year low of $42.99 and a 1-year high of $62.17.
Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Thursday, August 4th. The medical technology company reported $0.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.76 by $0.05. The company earned $655.40 million during the quarter, compared to analysts’ expectations of $647.75 million. Hill-Rom Holdings had a net margin of 2.47% and a return on equity of 16.62%. The firm’s quarterly revenue was up 38.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.62 earnings per share. On average, equities analysts predict that Hill-Rom Holdings Inc. will post $3.33 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Shareholders of record on Friday, September 16th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date of this dividend is Wednesday, September 14th. Hill-Rom Holdings’s payout ratio is currently 73.91%.
HRC has been the subject of a number of research analyst reports. Morgan Stanley raised shares of Hill-Rom Holdings from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $54.00 to $62.00 in a research report on Thursday, June 16th. KeyCorp reaffirmed a “buy” rating and set a $59.00 price objective on shares of Hill-Rom Holdings in a research report on Thursday, June 23rd. Finally, Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $64.00 price objective for the company in a research report on Tuesday, August 9th. Five analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $61.83.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.